國立高雄大學圖資館 |

登入

回首頁

Bioprocessing, bioengineering and process chemistry in the biopharmaceutical industryusing chemistry and bioengineering to improve the performance of biologics /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Bioprocessing, bioengineering and process chemistry in the biopharmaceutical industryedited by Kumar Gadamasetti, Stephen A. Kolodziej.
其他題名:	using chemistry and bioengineering to improve the performance of biologics /
其他作者:	Gadamasetti, Kumar G.
出版者:	Cham :Springer Nature Switzerland :2024.
面頁冊數:	xxiv, 559 p. :ill. (chiefly color), digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Pharmaceutical biotechnology.
電子資源:	https://doi.org/10.1007/978-3-031-62007-2
ISBN:	9783031620072$q(electronic bk.)

Bioprocessing, bioengineering and process chemistry in the biopharmaceutical industryusing chemistry and bioengineering to improve the performance of biologics /
Bioprocessing, bioengineering and process chemistry in the biopharmaceutical industryusing chemistry and bioengineering to improve the performance of biologics /[electronic resource] :edited by Kumar Gadamasetti, Stephen A. Kolodziej. - Cham :Springer Nature Switzerland :2024. - xxiv, 559 p. :ill. (chiefly color), digital ;24 cm.

Bioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry Using Chemistry and Bioengineering to Improve the Performance of Biologics An Overview -- Synthetic Biology in Drug Development and Beyond -- Increasing the Scalability of DNA Synthesis and Its Key Role in Expanding the Biopharmaceutical Discovery Process -- Advancements in the Manufacture of Monoclonal Antibodies and other Large Molecule Protein Therapeutics Recent Innovations in Cell Culture Technology Enabling Process Intensification -- Process Development and Manufacturing Considerations for Multispecific (Bispecific and Trispecific) Antibodies Case Studies -- Metabolic and process engineering to control glycan structures for biopharmaceuticals produced in cultured mammalian cells -- Even A Worm Will Turn Immunity Following AAV Vector Administration -- COVID-19 Vaccine Manufacturing Processes Making the Molecules to Solve the Pandemic -- CAR T Bioprocessing -- CRISPR Technology and its Application in Therapeutics -- Fusion Proteins Current Status and Future Perspectives -- Development of Antibody Drug Conjugates -- Mylotarg The Journey to FDA Reapproval and Broad International Approval -- Biopharmaceutical Informatics A Strategic Vision for Discovering Developable Biotherapeutic Drug Candidates -- Advanced Data Analytics Application in Bio manufacturing Processes -- Overview of Complexities of Global CMC Regulatory Affairs -- CMC Considerations for Continuous Bioprocess Design, Development and Manufacturing -- Three Decades of Advancements in Technical Transfer of Biologics a Blueprint for Advanced Therapeutics -- Emerging Biopharmaceutical Technologies and Trends.

This book outlines how advances in the diverse scientific and engineering disciplines of synthetic biology, DNA synthesis, production of protein therapeutics, and bioinformatics have led to the commercialization of new complex biotherapeutic modalities in modern era, including monoclonal and multi-specific antibodies, antibody drug conjugates (ADC), fusion proteins, CAR-T and CRISPR technologies and applications, mRNA vaccines and more. Enabling operations to bring these life-changing medicines into the hands of the needy patients include regulatory submissions to authorities across the globe, as well as streamlined production across manufacturing networks deemed necessary and are outlined in dedicated chapters. Bioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry: Using Chemistry and Bioengineering to Improve the Performance of Biologics captures the state of the art for many of these new modalities, offering innovative approaches to treat, prevent, and in some providential cases, cure the disease. This book will be of significant interest for many disciplines engaged jointly as teams convergently in delivering these medicines: bioprocess engineers, biologists, chemists, bioengineers, genetic engineers, healthcare professionals, regulatory bodies, among pharmaceutical industry professionals as well as in academic circles.

ISBN: 9783031620072$q(electronic bk.)

Standard No.: 10.1007/978-3-031-62007-2doiSubjects--Topical Terms:

189023
Pharmaceutical biotechnology.

LC Class. No.: RS380

Dewey Class. No.: 615.19

Bioprocessing, bioengineering and process chemistry in the biopharmaceutical industryusing chemistry and bioengineering to improve the performance of biologics /
LDR:04191nmm a2200325 a 4500 001 671904
003 DE-He213
005 20241124115222.0
006 m d
007 cr nn 008maaau
008 250325s2024 sz s 0 eng d
020 $a 9783031620072$q(electronic bk.)
020 $a 9783031620065$q(paper)
024 7 $a 10.1007/978-3-031-62007-2 $2 doi
035 $a 978-3-031-62007-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RS380
072 7 $a TGM $2 bicssc
072 7 $a TEC021000 $2 bisacsh
072 7 $a TGML $2 thema
082 0 4 $a 615.19 $2 23
090 $a RS380 $b .B615 2024
245 0 0 $a Bioprocessing, bioengineering and process chemistry in the biopharmaceutical industry $h [electronic resource] : $b using chemistry and bioengineering to improve the performance of biologics / $c edited by Kumar Gadamasetti, Stephen A. Kolodziej.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a xxiv, 559 p. : $b ill. (chiefly color), digital ; $c 24 cm.
505 0 $a Bioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry Using Chemistry and Bioengineering to Improve the Performance of Biologics An Overview -- Synthetic Biology in Drug Development and Beyond -- Increasing the Scalability of DNA Synthesis and Its Key Role in Expanding the Biopharmaceutical Discovery Process -- Advancements in the Manufacture of Monoclonal Antibodies and other Large Molecule Protein Therapeutics Recent Innovations in Cell Culture Technology Enabling Process Intensification -- Process Development and Manufacturing Considerations for Multispecific (Bispecific and Trispecific) Antibodies Case Studies -- Metabolic and process engineering to control glycan structures for biopharmaceuticals produced in cultured mammalian cells -- Even A Worm Will Turn Immunity Following AAV Vector Administration -- COVID-19 Vaccine Manufacturing Processes Making the Molecules to Solve the Pandemic -- CAR T Bioprocessing -- CRISPR Technology and its Application in Therapeutics -- Fusion Proteins Current Status and Future Perspectives -- Development of Antibody Drug Conjugates -- Mylotarg The Journey to FDA Reapproval and Broad International Approval -- Biopharmaceutical Informatics A Strategic Vision for Discovering Developable Biotherapeutic Drug Candidates -- Advanced Data Analytics Application in Bio manufacturing Processes -- Overview of Complexities of Global CMC Regulatory Affairs -- CMC Considerations for Continuous Bioprocess Design, Development and Manufacturing -- Three Decades of Advancements in Technical Transfer of Biologics a Blueprint for Advanced Therapeutics -- Emerging Biopharmaceutical Technologies and Trends.
520 $a This book outlines how advances in the diverse scientific and engineering disciplines of synthetic biology, DNA synthesis, production of protein therapeutics, and bioinformatics have led to the commercialization of new complex biotherapeutic modalities in modern era, including monoclonal and multi-specific antibodies, antibody drug conjugates (ADC), fusion proteins, CAR-T and CRISPR technologies and applications, mRNA vaccines and more. Enabling operations to bring these life-changing medicines into the hands of the needy patients include regulatory submissions to authorities across the globe, as well as streamlined production across manufacturing networks deemed necessary and are outlined in dedicated chapters. Bioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry: Using Chemistry and Bioengineering to Improve the Performance of Biologics captures the state of the art for many of these new modalities, offering innovative approaches to treat, prevent, and in some providential cases, cure the disease. This book will be of significant interest for many disciplines engaged jointly as teams convergently in delivering these medicines: bioprocess engineers, biologists, chemists, bioengineers, genetic engineers, healthcare professionals, regulatory bodies, among pharmaceutical industry professionals as well as in academic circles.
650 0 $a Pharmaceutical biotechnology. $3 189023
650 0 $a Biologicals. $3 667671
650 0 $a Biopharmaceutics. $3 224951
650 1 4 $a Biomaterials. $3 274415
650 2 4 $a Biomedical Engineering and Bioengineering. $3 826326
650 2 4 $a Biotechnology. $3 188829
650 2 4 $a Pharmaceutics. $3 913065
650 2 4 $a Green Chemistry. $3 785187
700 1 $a Gadamasetti, Kumar G. $3 985047
700 1 $a Kolodziej, Stephen A. $3 985048
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-62007-2
950 $a Chemistry and Materials Science (SpringerNature-11644)